OMX Nordic 40
2.523,26
PKT
-13,16
PKT
-0,52
%
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 16.06.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 16.06.22 | Kone Outperform | Credit Suisse Group | |
| 16.06.22 | Hennes Mauritz (H M, H&M) Overweight | Barclays Capital | |
| 15.06.22 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
| 15.06.22 | Hennes Mauritz (H M, H&M) Outperform | RBC Capital Markets | |
| 15.06.22 | Hennes Mauritz (H M, H&M) Hold | Deutsche Bank AG | |
| 15.06.22 | Hennes Mauritz (H M, H&M) Neutral | JP Morgan Chase & Co. | |
| 15.06.22 | Hennes Mauritz (H M, H&M) Hold | Jefferies & Company Inc. | |
| 15.06.22 | Hennes Mauritz (H M, H&M) Buy | UBS AG | |
| 15.06.22 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
| 14.06.22 | Fortum Overweight | JP Morgan Chase & Co. | |
| 14.06.22 | AstraZeneca Neutral | UBS AG | |
| 13.06.22 | Hennes Mauritz (H M, H&M) Outperform | RBC Capital Markets | |
| 13.06.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 13.06.22 | Kone Overweight | JP Morgan Chase & Co. | |
| 13.06.22 | Kone Equal Weight | Barclays Capital | |
| 13.06.22 | Novo Nordisk Overweight | Barclays Capital | |
| 08.06.22 | Novo Nordisk Buy | Deutsche Bank AG | |
| 07.06.22 | AstraZeneca Outperform | Credit Suisse Group | |
| 07.06.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 07.06.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 06.06.22 | ABB (Asea Brown Boveri) Outperform | Bernstein Research | |
| 06.06.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 06.06.22 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 06.06.22 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 03.06.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 02.06.22 | Kone Neutral | Goldman Sachs Group Inc. | |
| 02.06.22 | Kone Overweight | JP Morgan Chase & Co. | |
| 27.05.22 | Hennes Mauritz (H M, H&M) Hold | Jefferies & Company Inc. | |
| 27.05.22 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.05.22 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.05.22 | Hennes Mauritz (H M, H&M) Overweight | Barclays Capital | |
| 26.05.22 | Hennes Mauritz (H M, H&M) Neutral | JP Morgan Chase & Co. | |
| 25.05.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 25.05.22 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 24.05.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 24.05.22 | ABB (Asea Brown Boveri) Buy | UBS AG | |
| 24.05.22 | ABB (Asea Brown Boveri) Outperform | Bernstein Research | |
| 24.05.22 | Novo Nordisk Buy | Deutsche Bank AG | |
| 23.05.22 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. |